Loading…

Get local results

 Current general location:  
Enter your location to see results closest to you.
-or-
We do not share your location with anyone.

3C Project Blue Book

HybridTHC CBD
Product rating:
Strain rating:

About this product

3C Project Blue Book is like a more sophisticated Blue Dream, sativa in nature but backed by a
Project Blue Book is a unique cross grown exclusively by 3C farms. It is our most creative strain, perfect for writers, advertising executives, and other people that rely on creativity in their crafts. It has a sweet and citrusy aroma and flavor and is perfect for daytime use.

About this strain

Picture of Project Blue Book
Project Blue Book

3C Project Blue Book is like a more sophisticated Blue Dream; it’s sativa in nature, but backed by a serene body high. This sativa heavy hybrid is a cross between Blue Dream and 3C Majestic 12. Both powerful strains blend perfectly to create a clear, focused, and calming experience. Its name comes from a series of systematic studies regarding UFOs conducted by the United States. Light green colas carry the flavor and scent of roses and a freshly peeled orange, tickling the palate as the head high ascends.

Project Blue Book effects

Reported by real people like you
8 people told us about effects:
Happy
100% of people report feeling happy
Uplifted
62% of people report feeling uplifted
Euphoric
50% of people report feeling euphoric
Dry mouth
25% of people report feeling dry mouth
Anxious
12% of people report feeling anxious
Dry eyes
12% of people report feeling dry eyes
Depression
37% of people say it helps with depression
Pain
37% of people say it helps with pain
Stress
37% of people say it helps with stress
No product reviews
Have you tried this product? Be the first to leave a review!

About this brand

Logo for the brand 3C Farms
Californias resource for the highest quality medicinal cannabis in the industry. Helping people through cannabis is our passion, and every aspect of our brand works towards providing the best premium cannabis to our patients.